Asarfi Hospital Ltd
Incorporated in 2005, Asarfi Hospital Ltd
provides primary health services & treatment
and specialized super speciality health service[1]
- Market Cap ₹ 296 Cr.
- Current Price ₹ 151
- High / Low ₹ 154 / 60.0
- Stock P/E 27.8
- Book Value ₹ 43.0
- Dividend Yield 0.00 %
- ROCE 15.8 %
- ROE 14.1 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 32.4% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 13.9% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 43 | 54 | 65 | 69 | 81 | 116 | |
| 37 | 46 | 54 | 55 | 65 | 93 | |
| Operating Profit | 6 | 8 | 11 | 14 | 16 | 24 |
| OPM % | 15% | 15% | 17% | 20% | 20% | 20% |
| 0 | 0 | 1 | 2 | 2 | 8 | |
| Interest | 1 | 1 | 1 | 1 | 3 | 4 |
| Depreciation | 2 | 3 | 3 | 4 | 9 | 13 |
| Profit before tax | 4 | 5 | 8 | 11 | 6 | 15 |
| Tax % | 27% | 26% | 26% | 26% | 33% | 25% |
| 3 | 4 | 6 | 8 | 4 | 11 | |
| EPS in Rs | 21.48 | 28.83 | 46.79 | 5.53 | 2.14 | 5.58 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 21% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 32% |
| 3 Years: | 23% |
| TTM: | 154% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 151% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 14% |
| Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 14 | 20 | 20 |
| Reserves | 12 | 16 | 21 | 27 | 51 | 62 |
| 5 | 7 | 12 | 17 | 32 | 49 | |
| 9 | 13 | 28 | 34 | 52 | 34 | |
| Total Liabilities | 28 | 37 | 63 | 93 | 154 | 164 |
| 18 | 22 | 31 | 39 | 94 | 101 | |
| CWIP | 0 | 2 | 9 | 18 | 0 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 9 | 13 | 22 | 37 | 60 | 61 | |
| Total Assets | 28 | 37 | 63 | 93 | 154 | 164 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 2 | 10 | 9 | 7 | 26 | -4 | |
| -5 | -16 | -23 | -21 | -63 | -8 | |
| 2 | 6 | 14 | 15 | 36 | 13 | |
| Net Cash Flow | 0 | 0 | -0 | 1 | -1 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 20 | 14 | 30 | 90 | 109 | 125 |
| Inventory Days | 23 | 13 | 16 | 26 | 32 | 30 |
| Days Payable | 156 | 23 | 34 | 91 | 445 | 171 |
| Cash Conversion Cycle | -113 | 5 | 11 | 25 | -304 | -16 |
| Working Capital Days | -10 | -38 | -36 | 18 | 3 | 50 |
| ROCE % | 25% | 29% | 26% | 11% | 16% |
Documents
Announcements
-
Intimation Regarding Credit Rating - Asarfi Hospital Limited.
13 Oct - CRISIL assigned BBB-/Stable to Asarfi Hospital's Rs46.5 crore long-term bank facilities on October 13, 2025.
-
Closure of Trading Window
11 Oct - Trading window closed Oct 1, 2025 until 48 hours after unaudited Q2 (Sep 30,2025) results; board date pending.
-
Board Meeting Outcome for Intimation Of Appointment Of Cost Auditor
25 Sep - Appointed M/s Ashutosh Kumar Sinha & Co as cost auditor for FY2025-26 on 25/09/2025.
-
Disclosure Regarding Clerical Error In Debtors' Ageing Statement In The Financial Statements For The Year Ended March 31, 2025
20 Sep - Clerical misclassification in debtors' ageing for year ended March 31, 2025; total ₹3,979.73 unaffected.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 13 Sep
Annual reports
Concalls
-
Aug 2025TranscriptNotesPPT
-
May 2025Transcript PPT
-
Jan 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
Business Overview Asarfi Hospital Limited (AHL) operates three primary facilities:
a) Super Multi-Specialty Hospital (Baramuri, Dhanbad)[1]
- Structure and Capacity: This hospital spans four blocks and six floors, with a constructed area exceeding 100,000 square feet on 92 decimals of land. It houses 250 beds, with plans to expand capacity to 350 beds.
- Specializations: Cardiology and Neurology are major departments, generating nearly 50% of hospital revenue. Other key specialties include emergency care, general medicine, pediatrics, orthopedics, and obstetrics & gynecology.
b) Asarfi Cancer Institute (Ranguni, Dhanbad)[2]
- Location and Size: Built on 9.55 acres of leased land from the Jharkhand Industrial Area Development Authority (JIADA).
- Capacity and Occupancy: Currently, the Cancer Institute operates with 50 beds across two floors, achieving an average occupancy rate of 57% as of H1 FY25. Plans are underway to expand capacity to 150 beds with an additional investment of ₹2-3 crores.
- Unique Positioning: It is the only dedicated cancer hospital within a 200 km radius, offering specialized oncology services including medical, surgical, and radiation oncology.
- Future Expansion: The facility is approved for construction of up to seven floors, enabling substantial expansion.
c) Research Institute (Ranchi)[3]
- Location and Infrastructure: Located 4 km from Ranchi Airport, in proximity to HEC India, on 5.6 acres of acquired land for 13.5 Crs
- Development Plans: AHL plans to establish medical and non-medical research management courses by FY28. The land’s value has appreciated since its acquisition, estimated at ₹65 crores.